JPRN-UMIN000004568已完成2 期
Phase II study of oral S-1 plus oral leucovorin in patients with previously treated non-small-cell lung cancer - Oral S-1 with leucovorin in non-small cell lung cancer
Protocol team for S-1 with leucovorin therapy0 个研究点目标入组 32 人开始时间: 2010年11月16日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with symptomatic brain metastasis
研究者
相似试验
未知
2 期
Phase II Study of SOL and Bevacizumab Combination Therapy in patients with Untreated Metastatic Colorectal Cancer.JPRN-jRCT2080220850Taiho Pharmaceutical Co., Ltd.28
未知
2 期
A Randomized Phase II Study of S-1 plus Leucovorin versus S-1 alone in Patients with Gemcitabine-Refractory Advanced Pancreatic Cancer.Pancreatic cancerJPRN-jRCT2080221515Taiho Pharmaceutical Co., Ltd.140
已完成
2 期
Phase II study of S-1, leucovorin plus bevacizumab in refractory colorectal cancerColorectal cancerJPRN-UMIN000009083Aichi Cancer Center Hospital, Department of Clinical Oncology30
已完成
2 期
Phase II study of S-1 plus Leucovorin for metastatic pancreatic adenocarcinoma (JASPAC 03)metastatic pancreatic adenocarcinomaJPRN-UMIN000004958Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC)30
Unknown
1 期
Phase I/II Study of SOL for Untreated Metastatic Colorectal CancerColorectal CancerNCT00524706Shizuoka Cancer Center42